Clinical Trials

Study Title:
Phase III Randomized Trial of Stereotactic ablative radiotherapy (SAbR) for Oligometastatic Advanced Renal Carcinoma

For more information about the trial above please contact the study team:

Medical University of South Carolina
Principal Investigator, David Marshall, at marshadt@musc.edu.
Study Coordinator, Theresa Gelardi, at gelardi@musc.edu.

Trial opened at the following institutions: Medical University of South Carolina